Tactile Systems Technology INC

Tactile Systems Technology, Inc. has entered an exclusive U.S. distribution agreement with ElastiMed, Inc. for the MyoSleeve wearable compression device targeting VA and DoD patients.

Tactile Systems Technology, Inc. stockholders elected directors, ratified auditors, and approved a certificate of incorporation amendment at the 2026 Annual Meeting.

Tactile Systems Technology, Inc. announced a 23% year-over-year revenue increase to $75.3 million in Q1 2026, alongside improved gross margin and a shift to positive Adjusted EBITDA.

Tactile Systems Technology, Inc. announced robust third-quarter 2025 financial results, exceeding prior guidance and authorizing a new $25 million share repurchase program.

Tactile Systems Technology, Inc. reported a 7.8% year-over-year revenue increase to $78.9 million in Q2 2025, while net income and Adjusted EBITDA declined, leading to an updated full-year financial outlook.

Tactile Systems Technology, Inc. has adopted the 2025 Equity Incentive Plan, authorizing the issuance of up to 1,850,000 shares, and elected directors at its 2025 Annual Meeting of Stockholders.

Tactile Systems Technology reported a 23% increase in Q1 2026 revenue to $75.3 million, driven by strong lymphedema and airway clearance product sales, while net loss narrowed to $1.8 million.

Tactile Systems Technology, Inc. reported significant revenue and net income growth for Q3 2025, driven by strong performance in its airway clearance product line and strategic initiatives, while also fully repaying its term loan.

Tactile Systems Technology, Inc. reported an 8% revenue increase in Q2 2025, driven by airway clearance products, but net income declined 25% due to higher operating expenses.

Tactile Systems Technology's Q1 2025 results reveal a slight revenue increase offset by a higher net loss, alongside ongoing legal proceedings and a share repurchase program.

Tactile Systems Technology, Inc. announced a 5% increase in revenue for the third quarter of 2024 compared to the same period last year, alongside a net income of $5.2 million.

Tactile Systems Technology, Inc. reports a 7% increase in revenue and a return to profitability for the second quarter of 2024, driven by growth in its lymphedema product line.

Tactile Systems Technology, Inc. announces a 7% increase in revenue and a net income of $17.0 million for the year ended December 31, 2024, driven by growth in lymphedema product sales.

Tactile Systems Technology, a medical technology company, announced a successful 2023 with significant revenue growth and a return to profitability.

CFO Elaine M. Birkemeyer sold 4,631 shares of Tactile Systems Technology, Inc. to cover tax obligations related to stock unit settlements.

Director Valerie L. Asbury acquired 6,521 shares of Tactile Systems Technology, Inc. common stock via a restricted stock unit grant.

Tactile Systems Technology director Raymond Huggenberger was granted 6,521 restricted stock units as part of annual compensation.

Director Laura G. King acquired 6,521 shares of Tactile Systems Technology, Inc. common stock via a restricted stock unit grant.

Director Andrea Pearson acquired 6,521 shares of Tactile Systems Technology, Inc. common stock via a restricted stock unit grant.

Tactile Systems Technology director David Brent Shafer was granted 6,521 restricted stock units vesting in one year.

Tactile Systems Technology, Inc. announces its 2026 Annual Meeting of Stockholders agenda, including director elections, auditor ratification, executive compensation approval, and a corporate governance amendment.

Tactile Systems Technology, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 7, 2025, with key voting items including the election of directors, ratification of the independent auditor, and approval of executive compensation and an equity incentive plan.

Tactile Systems Technology is asking stockholders to approve the 2025 Equity Incentive Plan at the upcoming annual meeting, aiming to replace the existing 2016 plan and enhance long-term incentives.

Tactile Systems Technology, Inc. announces Daniel L. Reuvers' retirement as CEO, effective June 30, 2024, and the appointment of Sheri L. Dodd as the new CEO, effective July 1, 2024.

Tactile Systems Technology, Inc. will hold its annual stockholder meeting on May 8, 2024, to vote on the election of directors, ratification of the independent auditor, executive compensation, and an amendment to the company's certificate of incorporation.

Tactile Systems Technology is asking stockholders to approve an amendment to its corporate charter to limit the personal liability of certain officers, aligning their protections more closely with those of directors.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Tactile Systems Technology Inc. following an internal realignment.

Cadian Capital Management and its affiliates reported a 4.9% beneficial ownership stake in Tactile Systems Technology Inc. as of December 31, 2025.

Paradigm Capital Management Inc. has disclosed a 3.29% beneficial ownership stake in Tactile Systems Technology Inc. through an amended Schedule 13G filing.

Morgan Stanley and its subsidiary have reported beneficial ownership of 5.8% of Tactile Systems Technology Inc.'s common stock.

Dimensional Fund Advisors LP has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Tactile Systems Technology Inc. as of December 31, 2025.

The Vanguard Group updated its beneficial ownership in Tactile Systems Technology Inc., reporting a 7.06% stake as of September 30, 2025.